Us Bancorp \De\ Tiziana Life Sciences LTD Transaction History
Us Bancorp \De\
- $82.9 Billion
- Q3 2025
A detailed history of Us Bancorp \De\ transactions in Tiziana Life Sciences LTD stock. As of the latest transaction made, Us Bancorp \De\ holds 10,157 shares of TLSA stock, worth $17,266. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10,157Holding current value
$17,266% of portfolio
0.0%Shares
2 transactions
Others Institutions Holding TLSA
# of Institutions
33Shares Held
4.06MCall Options Held
32KPut Options Held
0-
Dauntless Investment Group, LLC Commerce Township, MI2.74MShares$4.65 Million4.04% of portfolio
-
Marshall Wace, LLP London, X0268KShares$455,6200.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny241KShares$409,3830.0% of portfolio
-
Morgan Stanley New York, NY97.1KShares$165,0730.0% of portfolio
-
Zhang Financial LLC84.2KShares$143,1400.01% of portfolio
About Tiziana Life Sciences Ltd
- Ticker TLSA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 102,273,000
- Market Cap $174M
- Description
- Tiziana Life Sciences Ltd, a biotechnology company, focuses on the discovery and development of molecules to treat human diseases in oncology and immunology. The company's lead product candidate in immunology is Foralumab (TZLS-401), a human anti-CD3 monoclonal antibody (mAb) for the treatment of Crohn's, graft versus host, ulcerative colitis, m...